WhatFinger

Pfizer Says Its COVID-19 Pill Paxlovid Fails to Prevent Symptomatic Infection of Household Members

By Epoch Times ——--May 1, 2022

News Headlines | CFP Comments | Reader Friendly | Subscribe | Email Us

Pfizer announced Friday that a recent large, late-stage trial found that its COVID-19 antiviral pill, Paxlovid, failed at preventing symptomatic infection of people living with a person who has the disease. The trial enrolled 2,957 participants aged 18 and older who live in the same household as another person who has COVID-19 with symptoms. They were given either Paxlovid or a placebo twice daily for five or 10 days.-- More...

Support Canada Free Press

Donate
Subscribe

View Comments
Epoch Times——

The Epoch Times: “A Fresh Look at Our Changing World”

The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.

 

We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.

VIEW Comments

Sponsored
!-- END RC STICKY -->